Universal 4SCAR7U Targeting CD7-positive Malignancies

Clinical trial NCT05995028 · RECRUITING

Trial details

NCT number: NCT05995028
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia T-cell Acute Lymphoblastic Lymphoma Acute Myeloid Leukemia NK Cell Lymphoma

Start date: 2023-10-31
Primary completion: 2026-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.